Literature DB >> 32492486

Prussian blue nanoparticles: synthesis, surface modification, and biomedical applications.

Maria Antònia Busquets1, Joan Estelrich2.   

Abstract

Prussian blue nanoparticles (PBNPs) are a nanomaterial that presents unique properties and an excellent biocompatibility. They can be synthesized in mild conditions and can be derivatized with polymers and/or biomolecules. PBNPs are used in biomedicine as therapy and diagnostic agents. In biomedical imaging, PBNPs constitute contrast agents in photoacoustic and magnetic resonance imaging (MRI). They are a good adsorbent to be used as antidotes for poisoning with cesium and/or thallium ions. Moreover, the ability to convert energy into heat makes them useful photothermal agents (PAs) in photothermal therapy (PTT) or as nonantibiotic substances with antibacterial properties. Finally, PBNPs can be both reduced to Prussian white and oxidized to Prussian green. A large window of redox potential exists between reduction and oxidation, which result in the enzyme-like characteristics of these NPs.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2020        PMID: 32492486     DOI: 10.1016/j.drudis.2020.05.014

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  12 in total

1.  Green Synthesis and Characterization of Carboxymethyl Cellulose Fabricated Silver-Based Nanocomposite for Various Therapeutic Applications.

Authors:  Muhammad Arif Asghar; Rabia Ismail Yousuf; Muhammad Harris Shoaib; Muhammad Asif Asghar; Mehrukh Zehravi; Ahad Abdul Rehman; Muhammad Suleman Imtiaz; Kamran Khan
Journal:  Int J Nanomedicine       Date:  2021-08-11

2.  Manganese-Based Prussian Blue Nanocatalysts Suppress Non-Small Cell Lung Cancer Growth and Metastasis via Photothermal and Chemodynamic Therapy.

Authors:  Danruo Fang; Zeyu Liu; Hansong Jin; Xiulin Huang; Yongxin Shi; Suqin Ben
Journal:  Front Bioeng Biotechnol       Date:  2022-06-22

3.  Mn doped Prussian blue nanoparticles for T1/T2 MR imaging, PA imaging and Fenton reaction enhanced mild temperature photothermal therapy of tumor.

Authors:  Quan Tao; Genghan He; Sheng Ye; Di Zhang; Zhide Zhang; Li Qi; Ruiyuan Liu
Journal:  J Nanobiotechnology       Date:  2022-01-04       Impact factor: 10.435

4.  Prussian Blue Scavenger Ameliorates Hepatic Ischemia-Reperfusion Injury by Inhibiting Inflammation and Reducing Oxidative Stress.

Authors:  Yongxin Huang; Qinyuan Xu; Jiang Zhang; Yanze Yin; Yixiao Pan; Yuanyi Zheng; Xiaojun Cai; Qiang Xia; Kang He
Journal:  Front Immunol       Date:  2022-05-25       Impact factor: 8.786

Review 5.  Prussian Blue: A Safe Pigment with Zeolitic-Like Activity.

Authors:  Joan Estelrich; Maria Antònia Busquets
Journal:  Int J Mol Sci       Date:  2021-01-15       Impact factor: 5.923

6.  Triggering Drug Release and Thermal-Disrupting Interface Induced Mitigation of Composite Photothermal Hydrogel Treating Infectious Wounds.

Authors:  Long Hua; Hu Qian; Ting Lei; Wenbin Liu; Xi He; Yihe Hu; Pengfei Lei
Journal:  Front Bioeng Biotechnol       Date:  2021-12-13

Review 7.  Nanotechnology-Based Diagnostic and Therapeutic Strategies for Neuroblastoma.

Authors:  Hui Yan; Bo Zhai; Fang Yang; Zhenliang Chen; Qiang Zhou; Ana Cláudia Paiva-Santos; Ziqiao Yuan; Yang Zhou
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

Review 8.  Advances in Antitumor Nano-Drug Delivery Systems of 10-Hydroxycamptothecin.

Authors:  Yukun Chen; Zhenzhi Wang; Xiaofan Wang; Mingliang Su; Fan Xu; Lian Yang; Lijun Jia; Zhanxia Zhang
Journal:  Int J Nanomedicine       Date:  2022-09-14

9.  Tumor-targeted/reduction-triggered composite multifunctional nanoparticles for breast cancer chemo-photothermal combinational therapy.

Authors:  Yun Yang; Danrong Hu; Yi Lu; Bingyang Chu; Xinlong He; Yu Chen; Yao Xiao; Chengli Yang; Kai Zhou; Liping Yuan; Zhiyong Qian
Journal:  Acta Pharm Sin B       Date:  2021-09-10       Impact factor: 14.903

Review 10.  Prussian Blue: A Nanozyme with Versatile Catalytic Properties.

Authors:  Joan Estelrich; M Antònia Busquets
Journal:  Int J Mol Sci       Date:  2021-06-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.